Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VDR | P11473 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.30 |
| ▸ | RELA | Q04206 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21160440 | 0.91 | VDR (0.38) | VDRMAPTALDH1A1NPC1TP53 | |
| SCHEMBL12913709 | 0.83 | VDR (0.43) | VDRMAPTALDH1A1NPC1RAB9A | |
| SCHEMBL12913705 | 0.79 | VDR (0.45) | VDRMAPTALDH1A1NPC1RAB9A | |
| SCHEMBL13203365 | 0.79 | RAB9A (0.40) | VDRMAPTALDH1A1NPC1TP53 | |
| SCHEMBL15892650 | 0.77 | CYP1A2 (0.38) | VDRMAPTALDH1A1NPC1TP53 | |
| SCHEMBL12913695 | 0.77 | GAA (0.49) | VDRMAPTALDH1A1KDM4ECYP1A2 | |
| SCHEMBL21160442 | 0.74 | PKM (0.43) | VDRMAPTALDH1A1KDM4ECYP1A2 | |
| SCHEMBL21160631 | 0.73 | HTR1A (0.41) | VDRMAPTALDH1A1KDM4ECYP1A2 | |
| SCHEMBL21160443 | 0.71 | KDM4E (0.36) | VDRMAPTSMN1; SMN2KDM4ECYP1A2 | |
| SCHEMBL15202635 | 0.70 | GAA (0.39) | MAPTALDH1A1NPC1TP53RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11215928-B2 | Composition for resist underlayer film formation, resist underlayer film and method for forming the same, and production method of a patterned substrate | JSR CORPORATION (JP) | 2022-01-04 | — | — | US | disclosed |
| US-20190212650-A1 | COMPOSITION FOR RESIST UNDERLAYER FILM FORMATION, RESIST UNDERLAYER FILM AND METHOD FOR FORMING THE SAME, AND PRODUCTION METHOD OF A PATTERNED SUBSTRATE | JSR CORPORATION (JP) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11215928-B2 | Composition for resist underlayer film formation, resist underlayer film and method for forming the same, and production method of a patterned substrate | TOP1, OXA1L, RER1 | VDR 4451/4885MAPT 3830/4885ALDH1A1 826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.